Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV, a foreign private issuer, for the month of September 2018. The filing, dated September 18, 2018, incorporates by reference a press release issued on September 17, 2018 (Exhibit 99.1). The registrant's principal executive office is located in Mechelen, Belgium. Note: The request metadata references "Lakefront Biotherapeutics NV," but the filing text explicitly identifies the registrant as Galapagos NV.
Key Financial Metrics
The provided filing text does not contain specific financial data. It serves as a cover document to incorporate a press release by reference. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text.
Material Changes
The filing text does not disclose specific material changes to financial position or operations. It indicates that a material event or announcement was made via the attached press release, but the content of that announcement is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It references the incorporation of the press release into various Registration Statements (Forms F-3 and S-8) but does not detail the substance of those statements.
Investor Verification Checklist
- Verify the content of the attached Exhibit 99.1 (Press Release dated September 17, 2018) to understand the specific material event triggering this filing.
- Confirm the registrant identity is Galapagos NV, not Lakefront Biotherapeutics NV, as indicated in the request metadata.
- Review the referenced Registration Statements (File Nos. 333-211765, 333-204567, etc.) for detailed financial context if the press release references them.
- Check subsequent filings for any financial updates related to the September 2018 announcement.